Specificity: This antibody is capable of recognizing methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 4-OH-METH.
Host: Human
Application: RIA, ELISA
Summary
Specifications
Antibody Isotype
IgG
Clone
S93T
Species Reactivity
N/A
Immunogen
The original antibody was generated by immunizing female BALB/c mice with a hapten called METH P6 or (S)-(+)-4-(5-carboxypentyl)methamphetamine.
Conjugate
Unconjugated
Applications
Application Notes
Suitable for use in RIA, ELISA. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
General Notes
The Hi-Puri™ Human Anti-Methamphetamine Monoclonal antibody (clone S93T, product code DMAB-CPDB128)is a monoclonal antibody specifically directed against Methamphetamine. This product is validated for use in RIA, ELISA. This antibody is capable of recognizing methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 4-OH-METH. DMAB-CPDB128 is purified by affinity purification and supplied as a liquid formulation in PBS. It is available in multiple sizes, including 100 μg, 200 μg, 500 μg, and 1 mg. For long-term storage, the product should be stored at −20°C and repeated freeze–thaw cycles should be avoided. The product is shipped on dry ice. This product is intended for research use only and is not intended for diagnostic use.
Target
Alternative Names
Methamphetamine; METH
Citations
Publication ()
Have you cited DMAB-CPDB128 in a publication? Let us know and earn a reward for your research.
My Review for Hi-Puri™ Human Anti-Methamphetamine Monoclonal antibody, clone S93T
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.